• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症发热:慢性透析患者白细胞致热原的产生。

Fever in uremia: production of leukocytic pyrogen by chronic dialysis patients.

作者信息

Jones P G, Kauffman C A, Port F K, Kluger M J

出版信息

Am J Kidney Dis. 1985 Oct;6(4):241-4. doi: 10.1016/s0272-6386(85)80180-3.

DOI:10.1016/s0272-6386(85)80180-3
PMID:3876765
Abstract

Uremic patients frequently have low baseline temperatures and a blunted febrile response to infection. We investigated the first step in the generation of a febrile response, the production of leukocytic pyrogen (LP) by blood monocytes, in 12 patients on chronic hemodialysis, five patients on continuous ambulatory peritoneal dialysis (CAPD), and 17 control subjects. No significant differences were found in the amount of LP produced by hemodialysis patients, CAPD patients, and control subjects. Uremic serum did not decrease LP production by monocytes from control subjects. Hemodialysis patients who were consistently hypothermic (mean oral predialysis temperature less than or equal to 35.6 degrees F) produced as much LP as those with more normal oral temperatures (mean oral predialysis temperature greater than or equal to 36.8 degrees F). Decreased production of LP does not explain the blunted febrile response noted in patients with chronic renal failure.

摘要

尿毒症患者常常基线体温较低,对感染的发热反应迟钝。我们研究了发热反应产生的第一步,即血液单核细胞产生白细胞热原(LP)的情况,研究对象包括12例接受慢性血液透析的患者、5例接受持续性非卧床腹膜透析(CAPD)的患者以及17名对照者。血液透析患者、CAPD患者和对照者产生的LP量未发现显著差异。尿毒症血清并未降低对照者单核细胞产生LP的量。体温持续过低(透析前平均口腔温度小于或等于35.6华氏度)的血液透析患者产生的LP与口腔温度较为正常(透析前平均口腔温度大于或等于36.8华氏度)的患者一样多。LP产生减少并不能解释慢性肾衰竭患者出现的发热反应迟钝现象。

相似文献

1
Fever in uremia: production of leukocytic pyrogen by chronic dialysis patients.尿毒症发热:慢性透析患者白细胞致热原的产生。
Am J Kidney Dis. 1985 Oct;6(4):241-4. doi: 10.1016/s0272-6386(85)80180-3.
2
Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.持续非卧床腹膜透析患者血浆脂蛋白(a)升高与蛋白质和葡萄糖的腹膜转运有关。
Nephron. 1996;72(2):135-44. doi: 10.1159/000188831.
3
Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
Kidney Int. 1992 Aug;42(2):424-5. doi: 10.1038/ki.1992.304.
4
[Assessment of nutrition in dialysis patients and chronic uremic patients].[透析患者和慢性尿毒症患者的营养评估]
Zhonghua Nei Ke Za Zhi. 1997 Nov;36(11):727-30.
5
Effect of CAPD and hemodialysis on parathyroid function.持续性非卧床腹膜透析和血液透析对甲状旁腺功能的影响。
Adv Perit Dial. 1996;12:239-44.
6
Fever in the elderly. Production of leukocytic pyrogen by monocytes from elderly persons.老年人发热。老年人单核细胞产生白细胞致热原。
Gerontology. 1984;30(3):182-7. doi: 10.1159/000212627.
7
Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients.尿毒症损害血液透析患者的单核细胞及单核细胞衍生的树突状细胞功能。
Kidney Int. 2007 Nov;72(9):1138-48. doi: 10.1038/sj.ki.5002425. Epub 2007 Aug 29.
8
Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.接受不同透析程序的尿毒症患者血浆及与脂蛋白(a)相关的血小板活化因子乙酰水解酶活性
Kidney Int. 1999 Dec;56(6):2276-85. doi: 10.1046/j.1523-1755.1999.00788.x.
9
Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure.血液透析和持续性非卧床腹膜透析对肾衰竭患者红细胞生成的影响。
Kidney Int. 1984 Feb;25(2):430-6. doi: 10.1038/ki.1984.35.
10
CAPD and bone marrow cell-cell interaction abnormality in end stage renal disease.持续性非卧床腹膜透析与终末期肾病中的骨髓细胞间相互作用异常
Int J Artif Organs. 1984 Mar;7(2):57-62.

引用本文的文献

1
Hypothermia in Uremic Dogs and Cats.尿毒症犬猫的体温过低
J Vet Intern Med. 2016 Sep;30(5):1648-1654. doi: 10.1111/jvim.14525. Epub 2016 Aug 2.
2
Septic shock in chronic dialysis patients: clinical characteristics, antimicrobial therapy and mortality.慢性透析患者的败血症性休克:临床特征、抗菌治疗和死亡率。
Intensive Care Med. 2016 Feb;42(2):222-32. doi: 10.1007/s00134-015-4147-9. Epub 2015 Nov 25.